Chief Executive Officer & Chief Financial Officer
Dr. Thomas Höger joined Apogenix GmbH as Chief Executive Officer and Chief Financial Officer in November 2005. Prior to this, he worked as a stock analyst for DZ BANK, Frankfurt (Germany) for five years. From 1997 to 2000, he headed the CNS research at BASF AG and Knoll AG. From 1992 to 1996, he held various research and management positions at BASF AG. 

Dr. Thomas Höger obtained his Ph.D. in 1991 for the doctoral work performed at the German Cancer Research Center (DKFZ) after having studied biology at the Universities of Kiel and Heidelberg, and the Massachusetts Institute of Technology (MIT, Cambridge, USA) as a Fulbright Scholar. In 2001, he gained a certification as a CEFA-analyst (“Certified European Federation of Financial Societies Financial Analyst”).
Phone: +49 (0)6221 58608 0
thomas.hoeger(at)apogenix.com

Chief Medical Officer & Chief Operating Officer 
Dr. Harald Fricke joined Apogenix GmbH as Chief Medical Officer and Chief Operating Officer in January 2006. Previously, he was responsible for global clinical development at Fresenius Biotech GmbH. Prior to this, he was head of Baxter Oncology’s clinical development department. From 1996 to 2001 he held various national and international management positions at SmithKline Beecham and GlaxoSmithKline, respectively.

Dr. Fricke obtained his M.D. in 1987 after having studied medicine at the University of Aachen and the University Lübeck. From 1987 to 1990, he worked as a postdoc at the Weizman Institute of Science in Israel. Following his accreditation as a specialist in internal medicine in 1993, he was awarded his ‘Habilitation’ in 1996 by Ludwig-Maximilian-University in Munich.  
Phone: +49 (0)6221 58608 0
harald.fricke(at)apogenix.com